News
4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone
FRIDAY, June 6, 2025 (HealthDay News) — Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in medication abortions. The request came Thursday from top officials in California, Massachusetts, New Jersey and New York.
In response to FDA safety review of mifepristone, 4 pro-abortion states hit back
Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, attorneys general from four pro-abortion states have fired back, filing (PDF) a petition asking the U.S. regulator to lift restrictions on the treatment.
A new peer-reviewed study by the pro-life Charlotte Lozier Institute (CLI) found no evidence to substantiate the popular ...
Four attorneys general filed a petition with the FDA to lift restrictions on the abortion medication mifepristone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback